Previous 10 | Next 10 |
Shares of Vaxart (NASDAQ: VXRT) surged 109.8% in January, according to data provided by S&P Global Market Intelligence , adding onto the colossal 1,530% gain the stock made across all of 2020. Essentially a penny stock at the start of last year, Vaxart vaulted to the...
A few days ago, Vaxart (NASDAQ: VXRT) was arguably the best-performing coronavirus vaccine stock of all time. If you had invested $5,000 in the stock last year, that principal would have grown into a stunning $205,000 by Feb. 2. But not even 24 hours later, Vaxart ...
On Feb 3, Vaxart announced "Positive" Preliminary Data from its Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate. Vaxart reported that the study reached primary and secondary endpoints of safety and immunogenicity. VXA-CoV2-1 induced potent CD8+ T-cell resp...
Vaxart (NASDAQ: VXRT) has seemingly fallen further behind in the coronavirus vaccine race. On Monday, the company unveiled preliminary data from a phase 1 study of its vaccine candidate, VXA-CoV2-1, that showed a potentially significant weakness. The company reported that its or...
Vaxart (NASDAQ: VXRT) ranked as one of the hottest coronavirus stocks of 2020. Its share skyrocketed over 1,500% last year as investors became increasingly excited about the biotech's oral COVID-19 vaccine candidate, VXA-CoV2-1. As of the market close on Tuesday, Vaxart's share pric...
Shares of Vaxart (NASDAQ: VXRT) plunged 58% on Wednesday after the biotech released data from a phase 1 study of its oral COVID-19 vaccine candidate, VXA-CoV2-1. Preliminary results from Vaxart's clinical trial showed VXA-CoV2-1 to be generally well-tolerated, with no severe...
Gainers: Tyme Technologies (TYME) +93%.Sino-Global Shipping America (SINO) +81%.Lizhi (LIZI) +70%.Cassava Sciences (SAVA) +48%.GW Pharmaceuticals (GWPH) +46%.CPS Technologies (CPSH) +41%.10X Capital Venture Acquisition (VCVC) +38%.Naked Brand (NAKD) +37%.SuperCom (SPCB) +34%.Am...
Vaxart (NASDAQ: VXRT) , an American biotechnology company, announced that its preliminary oral COVID-19 vaccine had demonstrated positive results in early-stage clinical trials featuring 35 healthy adults. Nevertheless, the company’s stock fell 60% during intraday trading. ...
Gainers: Tyme Technologies (TYME) +110%, GW Pharmaceuticals (GWPH) +47%, Zynerba Pharmaceuticals (ZYNE) +39%, SELLAS Life Sciences (SLS) +38%, InMed Pharmaceuticals (INM) +15%.Losers: Vaxart (VXRT) -51%, Moleculin Biotech (MBRX) -26%...
Vaxart (VXRT) shares slump ~56% after it announces disappointing preliminary data from its Phase 1 study of VXA-CoV2-1, its oral COVID-19 tablet vaccine candidate.However, the company said that neutralizing antibodies were not detected in most of the subjects who were part of t...
News, Short Squeeze, Breakout and More Instantly...
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the second quarter ended June 30, 2024 after the market close on Thursd...
— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 million — — Company well-capitalized to execute on multiple key clinical and regulatory milestones in COVID-19 and noroviru...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...